Celadon Partners SPV 24 13D and 13G filings for Senti Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
2025-03-17 3:01 pm Unchanged |
2025-03-06 | 13D | Senti Biosciences, Inc. SNTI |
Celadon Partners SPV 24 | 9,777,000 37.600% |
0 (Unchanged) |
Filing |
2025-03-13 4:31 pm Purchase |
2025-03-06 | 13D | Senti Biosciences, Inc. SNTI |
Celadon Partners SPV 24 | 9,777,000 37.600% |
9,777,000![]() (New Position) |
Filing |